Zealand Pharma A/S (ZLDPF) News Today $114.60 +0.14 (+0.12%) (As of 12/17/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartEarningsHeadlinesShort Interest All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 Time Period Zealand Pharma announces first participant enrolled in ZUPREME-1December 12, 2024 | markets.businessinsider.comBerenberg Bank Sticks to Their Buy Rating for Zealand Pharma (ZLDPF)December 11, 2024 | markets.businessinsider.comZealand Pharma starts Phase 2b trial for obesity drug candidate petrelintideDecember 10, 2024 | reuters.comZealand Pharma initiated with an Overweight at JPMorganNovember 8, 2024 | markets.businessinsider.comZealand Pharma’s 2024 Progress and Financial ResultsNovember 8, 2024 | markets.businessinsider.comZealand Pharma Announces Financial Results for the First Nine Months of 2024November 7, 2024 | markets.businessinsider.comZealand Pharma to start phase 2b trial for obesity drug candidate in Q4November 7, 2024 | reuters.comZealand Pharma conference call on November 7 at 2pm CET (8am ET) to present third quarter 2024 financial resultsNovember 1, 2024 | globenewswire.comNovo and Lilly contender Zealand Pharma heralds its obesity drug alternative: It's our 'crown jewel'October 11, 2024 | msn.comWegovy and Zepbound rival targeting 'next generation' of obesity drugs, Zealand Pharma CEO saysOctober 11, 2024 | cnbc.comZealand Pharma A/S (OTCMKTS:ZLDPF) Trading Down 2.3% - What's Next?Zealand Pharma A/S (OTCMKTS:ZLDPF) Trading Down 2.3% - Here's WhyOctober 10, 2024 | marketbeat.comZealand, Boehringer win FDA breakthrough status to treat fatty liverOctober 8, 2024 | reuters.comZealand Pharma Gets FDA Complete Response Letter for Hypoglycemia New Drug ApplicationOctober 8, 2024 | marketwatch.comUS FDA declines to approve Zealand's drug for low blood sugar in infantsOctober 8, 2024 | msn.comNew Zealand's Fonterra upgrades dividend payout policySeptember 30, 2024 | reuters.comJefferies Sticks to Their Buy Rating for Zealand Pharma (ZLDPF)September 11, 2024 | markets.businessinsider.comZealand Pharma A/S (OTCMKTS:ZLDPF) Trading Up 2%Zealand Pharma A/S (OTCMKTS:ZLDPF) Trading 2% HigherSeptember 7, 2024 | marketbeat.comJefferies Remains a Buy on Zealand Pharma (ZLDPF)August 20, 2024 | markets.businessinsider.comZealand Pharma A/S (OTCMKTS:ZLDPF) Hits New 52-Week High at $141.74Zealand Pharma A/S (OTCMKTS:ZLDPF) Hits New 12-Month High at $141.74August 16, 2024 | marketbeat.comZealand Pharma wants a big partner for its weight loss drugAugust 16, 2024 | msn.comZealand Pharma A-S earnings: here's what to expectAugust 15, 2024 | markets.businessinsider.comZealand Pharma seeks big pharma partners for obesity drug candidateAugust 15, 2024 | reuters.comShort Interest in Zealand Pharma A/S (OTCMKTS:ZLDPF) Rises By 21.4%Zealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) was the recipient of a large increase in short interest during the month of July. As of July 31st, there was short interest totalling 746,000 shares, an increase of 21.4% from the July 15th total of 614,500 shares. Based on an average trading volume of 2,400 shares, the days-to-cover ratio is currently 310.8 days.August 15, 2024 | marketbeat.comDestiny Pharma initiates research to explore XF drug potential for CFAugust 14, 2024 | markets.businessinsider.comFSD Pharma Rebrands As Quantum BioPharma: Major Share Consolidation AnnouncedAugust 12, 2024 | msn.comZealand Pharma conference call on August 15 at 2pm CET (8am ET) to present first half 2024 financial resultsAugust 12, 2024 | globenewswire.comZealand Pharma A/S (22Z.MU)August 3, 2024 | finance.yahoo.comZealand Pharma Appoints Eric Cox as Chief Commercial OfficerJuly 29, 2024 | globenewswire.com4 high-conviction stock picks from top ETF managers — including GMO and a fund up 90% since 2022July 24, 2024 | businessinsider.comCantor Fitzgerald Comments on Zealand Pharma A/S's FY2024 Earnings (OTCMKTS:ZLDPF)Zealand Pharma A/S (OTCMKTS:ZLDPF - Free Report) - Cantor Fitzgerald upped their FY2024 earnings estimates for Zealand Pharma A/S in a research report issued to clients and investors on Monday, July 22nd. Cantor Fitzgerald analyst P. Agrawal now expects that the company will post earnings of ($2.July 24, 2024 | marketbeat.comHere's What Could Help Zealand Pharma AS (ZLDPF) Maintain Its Recent Price StrengthJuly 19, 2024 | finance.yahoo.comZealand Pharma A/S (OTCMKTS:ZLDPF) Sets New 12-Month High at $140.28Zealand Pharma A/S (OTCMKTS:ZLDPF) Reaches New 52-Week High at $140.28July 5, 2024 | marketbeat.comZealand Pharma A/S (OTCMKTS:ZLDPF) Reaches New 1-Year High at $129.35Zealand Pharma A/S (OTCMKTS:ZLDPF) Hits New 12-Month High at $129.35June 28, 2024 | marketbeat.comZealand Pharma A/S (OTCMKTS:ZLDPF) Sets New 52-Week High at $111.55Zealand Pharma A/S (OTCMKTS:ZLDPF) Sets New 12-Month High at $111.55June 21, 2024 | marketbeat.comWeight loss drug contender Zealand Pharma jumps 23% on trial resultsJune 21, 2024 | cnbc.comZealand Pharma's drug reduces weight by 8.6% in early-stage studyJune 20, 2024 | reuters.comZealand Pharma says drug shows improvement in fatty liver disease patientsJune 6, 2024 | reuters.com'Not just a harmless medicine': Pharmacist concerned about safety as pseudoephedrine back on shelvesMay 27, 2024 | msn.comZealand Pharma Reports Low-Dose Results for New Obesity DrugMay 23, 2024 | marketwatch.comFY2024 Earnings Forecast for Zealand Pharma A/S (OTCMKTS:ZLDPF) Issued By Cantor FitzgeraldZealand Pharma A/S (OTCMKTS:ZLDPF - Free Report) - Cantor Fitzgerald issued their FY2024 EPS estimates for shares of Zealand Pharma A/S in a research note issued to investors on Tuesday, May 21st. Cantor Fitzgerald analyst P. Agrawal forecasts that the company will earn ($2.53) per share for theMay 23, 2024 | marketbeat.comZealand Pharma A/S (OTCMKTS:ZLDPF) Research Coverage Started at Cantor FitzgeraldCantor Fitzgerald assumed coverage on Zealand Pharma A/S in a report on Tuesday. They set an "overweight" rating for the company.May 21, 2024 | marketbeat.comZealand Pharma A/S (OTCMKTS:ZLDPF) Trading 1.3% Higher Zealand Pharma A/S (OTCMKTS:ZLDPF) Shares Up 1.3%May 21, 2024 | marketbeat.comZealand Pharma A-S is about to announce earnings — here's what Wall Street expectsMay 15, 2024 | markets.businessinsider.comExplainer: Does Zambia's bondholder deal mean it has resolved its default?May 2, 2024 | msn.comGovt's Pharmac funding boost 'doesn't go far enough', advocate saysMay 1, 2024 | msn.comZealand Pharma A/S (OTCMKTS:ZLDPF) Short Interest UpdateZealand Pharma A/S (OTCMKTS:ZLDPF - Get Free Report) was the target of a large growth in short interest in April. As of April 15th, there was short interest totalling 409,800 shares, a growth of 21.1% from the March 31st total of 338,500 shares. Based on an average trading volume of 4,000 shares, the days-to-cover ratio is currently 102.5 days.April 29, 2024 | marketbeat.comPharmac's budget boosted to $6.3b over next four yearsApril 29, 2024 | msn.comZealand Pharma A/S (OTCMKTS:ZLDPF) Shares Up 1.3%Zealand Pharma A/S (OTCMKTS:ZLDPF) Stock Price Up 1.3%April 25, 2024 | marketbeat.comAuckland to Northland expressway will boost GDP by $1.2b a year, report showsApril 17, 2024 | msn.comA Double-Dip Recession in the Land of the Long White CloudApril 17, 2024 | bloomberg.com Get Zealand Pharma A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLDPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Affordable AI Plays: 2 Stocks Under $10 with Huge Potential! (Ad)As we step into 2025, artificial intelligence (AI) stocks continue to dominate headlines, and now is the perfect moment to position yourself for the coming year’s potential. Our latest research has uncovered two must-buy AI stocks currently trading under $10/share – an affordable entry with promising growth potential. These stocks are flying under the radar, but it’s only a matter of time before they gain mainstream attention. 👉 Click here to access your FREE report now! ZLDPF Media Mentions By Week ZLDPF Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ZLDPF News Sentiment▼0.000.55▲Average Medical News Sentiment ZLDPF News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ZLDPF Articles This Week▼11▲ZLDPF Articles Average Week Get Zealand Pharma A/S News Delivered to You Automatically Sign up to receive the latest news and ratings for ZLDPF and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies FFNTF News Today AGNPF News Today ALST News Today ALVO News Today HIPH News Today LEAS News Today ARNI News Today AZNCF News Today AVVH News Today BTMDW News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (OTCMKTS:ZLDPF) was last updated on 12/18/2024 by MarketBeat.com Staff From Our PartnersThis drone stock is setting up to transform medical supply deliveryDrone stocks are on a tear, with certain symbols seeing gains as high as 300% over just a matter of weeks.The Tomorrow Investor | SponsoredHealthcare Takes A Big Step Forward With The Help of A.I.To date, we've seen baseline AI models lay the groundwork. Tools like ChatGPT are useful, but they are still s...Wall Street Star | Sponsored Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredUncover the Top Gold Stock of the Bull MarketGold Stocks Are Surging—Is West Red Lake Gold Mines Your Next Profit Play?Huge Alerts | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowIt’s here. This is the moment we’ve been waiting for. The next 3-6 months in crypto will be absolutely life...Crypto Swap Profits | SponsoredFREE Book That Could Make You a Millionaire[FREE BOOK] Can You Make a Fortune in Crypto with $50? Get started now before the market takes off! Crypto 101 Media | SponsoredDo this Before Elon’s Reveal on January 22ndElon’s newest tech could pay you an extra $30,000 a year — while you sleep. It’s smaller than a quarter but...Brownstone Research | SponsoredSeeing is believing… Today, I want to share all the details with you… and show you how to leverage this incredible wealth-building ...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Zealand Pharma A/S Please log in to your account or sign up in order to add this asset to your watchlist. Share Zealand Pharma A/S With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ZLDPF Stock Alerts